Materials and methods: BRAF-mutated melanoma cell lines M14, A375 and LOX-IMVI (BRAF V600E), WM115 and WM266 (BRAF V600D) were exposed to BRAFi and/or MEKi treatments at different times. The gene discussed is BRAF; the disease is melanoma.